Inventor · disambiguated record
Phanesh Koneru
Also filed as: KONERU PHANESH · KONERU PHANESH B
33 granted patents·4 pending applications·197 citations·filing 2005–2024
97Inventor score
Files withEXELA PHARMA SCIENCES LLC23EXELA HOLDINGS INC5EXELA STERILE MEDICINES LLC4EXELA PHARMSCI INC3KONERU PHANESH1
Top patents by PatentIndex Score
37 records- 0198US10478453B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2019·Granted Nov 19, 2019·22 cites·22 claims
- 0297US11510942B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2021·Granted Nov 29, 2022·9 cites·34 claims
- 0397US11510941B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2021·Granted Nov 29, 2022·11 cites·17 claims
- 0497US10933089B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Mar 2, 2021·13 cites·27 claims
- 0597US10918662B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 16, 2021·13 cites·29 claims
- 0697US10912795B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 9, 2021·13 cites·29 claims
- 0797US10905713B2Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 2, 2021·13 cites·27 claims
- 0897US10905714B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 2, 2021·13 cites·29 claims
- 0997US10653719B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted May 19, 2020·14 cites·27 claims
- 1097US10583155B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2019·Granted Mar 10, 2020·15 cites·30 claims
- 1195US11141430B1Phosphate compositions with a low aluminum contentEXELA STERILE MEDICINES LLC·Filed 2020·Granted Oct 12, 2021·6 cites·18 claims
- 1293US11266621B1Methocarbamol composition and related methodsEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Mar 8, 2022·2 cites·21 claims
- 1392US12186338B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2024·Granted Jan 7, 2025·0 cites·21 claims
- 1492US12171781B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2024·Granted Dec 24, 2024·0 cites·30 claims
- 1591US11969439B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2023·Granted Apr 30, 2024·0 cites·30 claims
- 1691US11510893B1Methocarbamol composition and related methodsEXELA STERILE MEDICINES LLC·Filed 2022·Granted Nov 29, 2022·1 cites·20 claims
- 1789US11826383B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2023·Granted Nov 28, 2023·0 cites·30 claims
- 1889US10028921B1Phytonadione compositions and related methodsEXELA HOLDINGS INC·Filed 2016·Granted Jul 24, 2018·5 cites·12 claims
- 1988US11096907B2Phytonadione compositions and related methodsEXELA HOLDINGS INC·Filed 2018·Granted Aug 24, 2021·4 cites·19 claims
- 2087US11648262B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted May 16, 2023·0 cites·30 claims
- 2187US11642370B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted May 9, 2023·0 cites·30 claims
- 2287US11077071B2Phytonadione compositions and related methodsEXELA HOLDINGS INC·Filed 2018·Granted Aug 3, 2021·3 cites·12 claims
- 2386US11684636B1Stable, highly pure l-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 27, 2023·0 cites·30 claims
- 2485US11679125B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 20, 2023·0 cites·27 claims
- 2584US11672824B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 13, 2023·0 cites·30 claims
- 2684US7765110B1Method and system for delivering substitute medical therapies with restricted accessEXELA PHARMSCI INC·Filed 2006·Granted Jul 27, 2010·15 cites·40 claims
- 2784US2025177343A1Methocarbamol compositions and related methodsEXELA STERILE MEDICINES LLC·Filed 2024·Application pending·0 cites
- 2883US7885824B1Method and system for delivering medical therapiesEXELA PHARMSCI INC·Filed 2006·Granted Feb 8, 2011·15 cites·24 claims
- 2982US7885827B1Method and system for delivering substitute medical therapies with restricted accessEXELA PHARMSCI INC·Filed 2010·Granted Feb 8, 2011·7 cites·40 claims
- 3081US12161617B2Methocarbamol compositions and related methodsEXELA STERILE MEDICINES LLC·Filed 2022·Granted Dec 10, 2024·0 cites·20 claims
- 3181US11723978B2Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Aug 15, 2023·1 cites·18 claims
- 3281US2025319189A1Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2024·Application pending·0 cites
- 3378US2024181064A1Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2023·Application pending·0 cites
- 3476US9486530B1Ganciclovir compositions and related methodsMallipeddi Sreerama Murthy·Filed 2014·Granted Nov 8, 2016·2 cites·19 claims
- 3571US12064401B2Phytonadione compositions and related methodsEXELA HOLDINGS INC·Filed 2021·Granted Aug 20, 2024·0 cites·11 claims
- 3668US12070439B2Phytonadione compositions and related methodsEXELA HOLDINGS INC·Filed 2021·Granted Aug 27, 2024·0 cites·20 claims
- 3754US2006129433A1Method and system for delivering high risk medical therapiesKONERU PHANESH·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Phanesh Koneru files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →